NeuroSense Therapeutics Ltd.
NRSN | NASDAQ
$1.99
-$0.14 (-6.57%)
At close: Oct 30, 2026, 4:00 PM ET
$1.99
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.75 | -2.18 | -0.95 | -1.14 | -10.70 | -7.92 |
PEG Ratio | 0.09 | 0.06 | 0.04 | 0 | 0.19 | -0.06 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -12.56 | 8.64 | -6.09 | 2.50 | 2.97 | 33.83 |
P/FCF Ratio | -2.55 | -2.20 | -1.28 | -1.83 | -17.16 | -31.67 |
P/OCF Ratio | -2.55 | -2.20 | -1.28 | -1.85 | -17.35 | -32.08 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.11 | 0.03 | -0.08 | 0.04 | n/a | n/a |
Quick Ratio | 0.31 | 2.21 | 0.84 | 4.28 | 19.41 | 6.08 |
Current Ratio | 0.31 | 2.21 | 0.84 | 4.28 | 19.12 | 6.08 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -31.84 | -21.91 | -903.47 | -4.84 | n/a |
Return on Equity | 713.14% | -395.28% | 574.59% | -219.61% | -44.87% | -429.14% |
Return on Assets | -1.08K% | -223.17% | -317.33% | -160.05% | -35.35% | -363.03% |
Return on Invested Capital | 797.48% | -372.82% | 5.88K% | -224.07% | -51.57% | -438.24% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NRSN